1-6 of 6
Julia Gould, BA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Chemotherapy with Carfilzomib, Bendamustine and Dexamethasone Is Highly Active for Therapy of Newly Diagnosed Multiple Myeloma-Results of Single Center Phase I/II Study

Divaya Bhutani, MD, Siyang Leng, MD, Samuel Pan, Amer Assal, MD, Alexander Wei, Julia Gould, BA, Markus Y. Mapara, MD PhD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3196.
https://doi.org/10.1182/blood-2019-130207
Published: 2019
Journal Articles

An Open-Label Phase I/II Study of Carfilzomib, Bendamustine and Dexamethasone (CBD) in Newly Diagnosed Multiple Myeloma Patients

Siyang Leng, MD, Shahzad Raza, MD, Amer Assal, MD, Gregory Baliko, BS, Julia Gould, BA, Rachel K Shields, BA, Markus Y Mapara, MD PhD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1863.
https://doi.org/10.1182/blood.V130.Suppl_1.1863.1863
Published: 2017
Journal Articles

Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis

Camille Vanessa Edwards, MBBS, BSc, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Y Mapara, MD PhD, Jai Radhakrishnan, MD, Mathew S. Maurer, MD, Shahzad Raza, MD, John G. Mears, MD, Siyang Leng, MD, Jonathan S. Wall, PhD, Andrew Eisenberger, MD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 509.
https://doi.org/10.1182/blood.V130.Suppl_1.509.509
Published: 2017
Journal Articles

Long Term Follow up of Patients with Relapsed/Refractory Systemic Light Chain (AL) Amyloidosis Treated with Bendamustine and Dexamethasone in a Phase 2 Study

Galina G. Lagos, MD, Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Jeffrey A Zonder, MD, Keren Osman, MD, Julia Gould, BA, Wei-Yann Tsai, PhD, Silva Pregja, MBA, Mariamne Reyna, BS, Shahzad Raza, MD, Vaishali Sanchorawala, MD, Heather Landau, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1838.
https://doi.org/10.1182/blood.V130.Suppl_1.1838.1838
Published: 2017
Journal Articles

Final Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone in Patients with Previously Treated Systemic Light-Chain (AL) Amyloidosis

Galina Grigoriev Lagos, MD, Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Jeffrey Zonder, MD, Keren Osman, MD, Julia Gould, BA, Wei-Yann Tsai, Silva Pregja, MBA, Mariamne Reyna, BS, Shahzad Raza, MD, Vaishali Sanchorawala, MD, Heather Landau, MD
Journal: Blood
Blood (2016) 128 (22): 4523.
https://doi.org/10.1182/blood.V128.22.4523.4523
Published: 2016
Journal Articles

Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Camille V Edwards, MD, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Mapara, MD PhD, Jai Radhakrishnan, MD, Matthew S Maurer, MD, Shahzad Raza, MD, John G Mears, MD, Jonathan S Wall, PhD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2016) 128 (22): 643.
https://doi.org/10.1182/blood.V128.22.643.643
Published: 2016